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(57) ABSTRACT
Chemical pretreatments are used to produce usable water by
treating a water source with a chemical pretreatment that
contains a hexavalent chromium and an acid to generate a
treated water source, wherein the concentration of sulfate
compounds in the acid is negligible, and wherein the treated
water source remains substantially free of precipitates after
the addition of the chemical pretreatment. Other methods
include reducing the pH in urine to be distilled for potable
water extraction by pretreating the urine before distillation
with a pretreatment solution comprising one or more acid
sources selected from a group consisting of phosphoric acid,
hydrochloric acid, and nitric acid, wherein the urine remains
substantially precipitate free after the addition of the pre-
treatment solution. Another method described comprises a
process for reducing precipitation in urine to be processed
for water extraction by mixing the urine with a pretreatment
solution comprising hexavalent chromium compound and
phosphoric acid.
19 Claims, 3 Drawing Sheets
2,000 - -
1,600
~ 1,500 --- ---------— ----O
r3
E 1400 .............................................................................................................................
1,200 - __.-.._____ ___...._._.....g..........._... ...............Q _._
ci 1,00E - -
600 -- _ ._____._________ ______..._____ H2SO40
400 O H3PO
O HCI
2D0 — -- -- A HNO3
D
0.5 1.0 1.5 2.0 2.5 3.0 3.5
pH of Ersatz Brine Solution
https://ntrs.nasa.gov/search.jsp?R=20180002507 2019-08-29T22:21:55+00:00Z
U.S. Patent Jan. 30, 2018 Sheet 1 of 3 US 9,878,928 B1
2,000 e
1,800
1,500 ---- - - - -- __ ___ -
1,400-
E
1,200 ~~.
1,000 -- -- ---- - ----------------------------- ----
800 ....................
800 0 H2SO4
400 - _ -_- - ................................. 0 H3PO4
0 HCI
200 - - - A HNO3
0
0.5 1.0 1.5 2.0 2.5 3,0 3.5
pH of Ersatz Brine Solution
FIG.
U.S. Patent
4.0
3,5
3.0
2.5
Q 2.0
a~
1.5
E
E
b..
a, 1.0
0.5
Rol
Jan. 30, 2018 Sheet 2 of 3 US 9,878,928 B1
195
Pretreatment Acid
FIG..
U.S. Patent Jan. 30, 2018 Sheet 3 of 3 US 9,878,928 B1
4.0
3.5
a 3.0
E 
2..5
Cn
2,0
CL
` 1.5
E
0.5
0.0
Pretreatment Acid
US 9,878,928 B1
PRETREATMENT SOLUTION FOR WATER
RECOVERY SYSTEMS
CROSS REFERENCE TO RELATED
APPLICATIONS
This application claims benefit under 35 U.S.C. § 119(e)
of U.S. Provisional Patent Application No. 61/775,863, filed
on Mar. 11, 2013 and entitled "Pretreatment System for
Water Recovery Systems," which is hereby incorporated by
reference.
ORIGIN OF THE DISCLOSURE
The disclosure described herein was made in the perfor-
mance of work under a NASA contract and is subject to the
provisions of Section 305 of the National Aeronautics and
Space Act of 1958, Public Law 85-568, now codified at 51
U.S.C.§ 20135.
BACKGROUND
In environments having limited water resources or water
sources that have been contaminated by minerals or micro-
organisms, the development and commercialization of sys-
tems and methods to regenerate potable water from available
resources is paramount. To this end, a number of chemical
and physical purification techniques have been developed to
overcome these issues.
Physical filtration methods and chemical distillation have
been used to generate water products that range from potable
water for drinking to grey water for use in agriculture,
sanitation, and the like. In certain enclosed environments,
such as spacecraft, space stations, and biospheres, it is often
desirable to provide potable water by recycling waste waters
including high salinity brines and urine.
For example, in a manned spacecraft, water recovery from
urine allows astronauts to subsist on a relatively reduced
water reservoir supply, which can substantially decrease the
costs associated with transporting water supplies and
increases self-sustainability in cases where resupply may not
be instantly available. However, current methods for recov-
ering potable water from urine and brine are still limited on
the amount of water that may be recovered, and limits on the
efficiency of water recovery remain.
SUMMARY
This summary is provided to introduce a selection of
concepts that are further described below in the detailed
description. This summary is not intended to identify key or
essential features of the claimed subject matter, nor is it
intended to be used as an aid in limiting the scope of the
claimed subject matter.
In one aspect, methods described herein are directed to
methods of extracting potable water that include treating a
water source with a chemical pretreatment containing a
hexavalent chromium and an acid to generate a treated water
source, wherein the concentration of sulfate compounds in
the acid is negligible, and wherein treated water source
remains substantially free of precipitates after the addition of
the chemical pretreatment.
In yet another aspect, methods described herein are
directed to methods of reducing the pH in urine to be
distilled for potable water extraction that include pretreating
the urine before distillation with a pretreatment solution
comprising one or more acid sources selected from a group
2
consisting of phosphoric acid, hydrochloric acid, and nitric
acid, wherein the urine remains substantially precipitate free
after the addition of the pretreatment solution.
Other aspects and advantages of the disclosure will be
5 apparent from the following description and the appended
claims.
BRIEF DESCRIPTION OF DRAWINGS
to FIG. 1 is an illustration of the improved solubility of
calcium sulfate in brines containing chemical pretreatments
in accordance with embodiments of the present disclosure.
FIG. 2 is an illustration of the decreased content of total
suspended solids for brines containing chemical pretreat-
15 ments in accordance with embodiments of the present dis-
closure.
FIG. 3 is an illustration of the decreased content of total
suspended solids after partial water recovery by distillation
for brines containing chemical pretreatments in accordance
20 with embodiments of the present disclosure.
DETAILED DESCRIPTION
Embodiments disclosed herein relate to chemical pretreat-
25 ments for contaminated water sources, including brines,
seawater, brackish water, urine, and other forms of waste-
water, that may improve downstream processing operations
such as distillation or filtration. In particular embodiments,
methods of treating water sources are disclosed that utilize
30 chemical pretreatments that may adjust the pH to improve
the solubility of particular species in a given water source,
which may in turn decrease scaling and fouling caused by
the precipitation of weakly soluble compounds during sub-
sequent water recovery operations. Weakly soluble com-
35 pounds may include various sulfates, carbonates, and sili-
cates, for example.
Embodiments disclosed herein may also be directed to the
treatment of a water source contaminated with microorgan-
isms, such as microbes, viruses, or fungi, in which the
4o addition of a chemical pretreatment may kill existing micro-
organisms and/or prevent further growth. The use of chemi-
cal pretreatments as disclosed herein may also stabilize
treated water sources by acting as a buffer solution that
prevents the degradation of volatile species, which may then
45 allow for collection and storage of a water source for
extended periods of time without the need for additional pH-
and/or temperature-controls.
In general, the extraction of potable water from water
sources containing mineral and/or microorganism contami-
5o nation in accordance with the embodiments described herein
may involve at least three steps: (1) chemical pretreatment
of a water source; (2) water recovery from the treated water
source through distillation or membrane filtration; and (3)
transport and storage of a resulting concentrated waste
55 product.
In one aspect, the present disclosure addresses the prob-
lem of precipitate formation in distillation processes or
membrane filtration systems that may occur during water
extraction from a treated water source. For brines and other
60 solutions that contain poorly soluble materials, removal of
the water solvent decreases the solute capacity of the
remaining solution, which may trigger precipitation of solids
that can clog and foul distillation equipment or filtration
membranes. Further, the addition of chemical pretreatments
65 to a water source may also exacerbate this problem by
increasing the concentration of species that initiate the
precipitation of a number of slightly soluble minerals and
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organic materials. The problem of precipitation is particu-
larly important in water purification applications because the
buildup of precipitates can lead to decreased overall water
recovery and may also require the shutdown of purification
processes for repair or replacement of parts before purifi-
cation can resume.
The inventor providing the instant disclosure has discov-
ered precipitation after the addition of a chemical pretreat-
ment or stabilizer solution may be controlled by providing a
mineral acid that has an absence, or negligible concentra-
tion, of sulfates or sulfate-producing compounds. Accord-
ingly, a greater recovery rate of potable water may be
obtained from a given water source before damage to
purification equipment caused by the precipitation of poorly
soluble contaminants occurs.
The term "negligible" as used herein means that the
concentration of the specified solute is below a threshold
that may detrimentally effect the solubility of other solutes
that may be present in a given solution or produce a
precipitate, which, in one or more embodiments, may be less
than 5% by total mass of the solution, less than 2.5% by total
mass of the solution, or less than 1% by mass of the total
solution.
For example, during the treatment of urine as a water
source, there are two sources of sulfate, the first being
sulfates naturally present in the urine and the second being
those introduced with the pretreatment chemicals. The per-
cent water recovery desired without precipitation may also
be a factor in determining how much sulfate may be in the
pretreatment solution. In the instance that the target recovery
is 85% or greater without sulfate precipitation, it may be
necessary to add a pretreatment solution having a reduced
concentration of sulfates.
In one or more embodiments of the present disclosure,
chemical pretreatments may be used to treat a water source
before extraction of a purified water product by adding the
chemical treatment to the water source at a percent by
volume (vol %) that ranges from a lower limit selected from
the group of 0.5 vol %, 0.75 vol %, 1 vol %, 2.5 vol %, 5
vol %, and 7.5 vol %, to an upper limit of 2.5 vol %, 5 vol
%, 7.5 vol %, 10 vol %, 15 vol %, and 20 vol %, where the
vol % of the chemical pretreatment may range from any
lower limit to any upper limit. Depending on the type of
water source to be treated, the desired amount for chemical
pretreatment may vary. For example, in the extraction of
water from urine, a particularly desirable amount of chemi-
cal pretreatment to treat urine may be an amount added that
is enough to raise the concentration of the chemical pre-
treatment to a vol % of the total solution within the range of
0.5 vol % to 10 vol % in some embodiments, from 1 vol %
to 7 vol % in other embodiments, and from 1.5 vol % to 5
vol % in yet other embodiments. The range may be adjusted
depending on the concentration of solids, minerals, or other
contaminants in a given water source and the temperature-
or pressure-dependent variations of the water source vol-
ume.
In some embodiments, chemical pretreatments described
herein may be used in conjunction with filtration-based
methods to extract potable or grey water from a given water
source. For example, water may be extracted from treated
water source using reverse osmosis filtration. During filtra-
tion methods, after a water source is treated, a water product
may be generated by passing a portion of the water stream
through a filter membrane. The remaining waste stream
containing the concentrated solutes or particulates is carried
away from the membrane and either recycled or disposed of.
The use of chemical pretreatments that minimize the for-
4
mation of precipitates in filtration methods are also desir-
able, because colloidal and particulate contaminants may
build up on membrane filter surfaces and cause fouling and
damage.
5 Other water purification techniques may be incorporated
into the methods of the present disclosure, such as mem-
brane processes, sub-micron or nano-scale filtration, ion
exchange, UV treatment, and ozone treatment methods.
Moreover, a combination of filtration and distillation may be
10 
applied to purify water sources in some embodiments.
In other embodiments, purified and/or potable water may
be generated from a treated water source using any number
of distillation methods. Distillation processes utilize vola-
15 tilization or evaporation and subsequent condensation in
order to separate water from a more complex solution. In
one or more embodiments, distillation may be performed by
heating a treated water source to the boiling point of water
at a given pressure, or decreasing pressure until vaporization
20 occurs at a given temperature. However, chemical pretreat-
ments described herein may be adapted with other distilla-
tion methods, such as vacuum-based methods, freeze-dry-
ing, or electrolysis to produce vapor from water.
In particular applications, chemical pretreatments in
25 accordance with the present disclosure may be used in
combination with one or more water purification techniques
to extract potable water from urine. More than 140 different
substances generally are found in urine. These substances
may be broadly categorized as electrolytes, nitrogenous
30 substances, vitamins, metabolites, and hormones. About
seventy percent of the total weight of these materials is
accounted for by just two components, urea (50%) and
sodium chloride (20%). A breakdown which lists the most
35 
abundant components of urine is presented in Table 1 below.
TABLE 1
Major Constituents of Human Urine.
40 Concentration
Constituent Formula in urine, mg/L
Urea HzNCON 12 23,800
Sodium Chloride NaCl 9,450
Sodium Na 3,180
Potassium K 1,590
45 Calcium Ca 260
Creatinine C4H7N3O 954
Phosphorus P 875
Sulfur S 794
Ammonia NH3 555
Hippuric Acid C6H5CONHCH2CO2H 555
50 Uric Acid C5H4N4O3 555
Other 5,202
Totals 47,600
In embodiments where distillation is used to recover
55 potable water, it is possible for all of these materials to
appear as contaminants in urine distillate. In practice, how-
ever, it has been found that only a few components are
troublesome in purification processes. Contamination of the
distillate may be substantially avoided by pretreating the
60 urine with a chemical pretreatment in accordance with the
present disclosure that contains an effective amount of
water-soluble hexavalent chromium. The use of the chemi-
cal pretreatments may serve to substantially prevent or
minimize, for example: (1) distillation of dissolved gases
65 such as ammonia and unidentified odoriferous substances
which, upon distillation, redissolve in the distillate and
contaminate the same; and (2) decomposition of salts such
US 9,878,928 B1
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as urea and other urine solutes to gases which are liberated
during evaporation and redissolve in the distillate as con-
taminants.
The composition of urine given in Table 1 is merely
illustrative; urine specimens will vary from individual to
individual. For example, the free ammonia content of ran-
domly sampled urine varies from 0 to about 1,500 milli-
grams per liter (mg/L). If no preventive action is taken when
distilling urine as a water source, ammonia, generally pres-
ent as the carbonate or bicarbonate salt, may be transported,
together with the liberated carbon dioxide and water vapor,
from the system evaporator to its condenser.
The purification of urine as a water source also introduces
further complications due to the presence of naturally occur-
ring enzymes and microorganisms. For example, urea pres-
ent in urine decomposes in the presence of the extracellular
enzyme urease produced by bacteria that are invariably
present in urine samples. Once introduced to a urine supply,
bacteria multiply rapidly and will within a short time, e.g.,
12 to 48 hours, decompose most of the urea. Characteristi-
cally, the urine gradually becomes basic as bacterial urease
produces ammonia from urea according to the equation:
H2NCONH2+H20~2NH3+CO2 (Eq. 1)
However, the treatment of microbe-contaminated water
sources with hexavalent chromium may be effective as a
mechanism for killing microbes and/or arresting microbial
growth. Hexavalent chromium may easily penetrate cellular
membranes and may effect toxicity by damaging membrane
integrity, inhibiting enzymes within the electron transport
chain, and other enzymatic activities crucial to microbial
metabolism. In addition, hexavalent chromium also acts as
an oxidizer to destroy nucleic acids and other essential
organic molecules present in microbial cells. Thus, hexava-
lent chromium is bi-functional in its prevention of microbial
decomposition of urea to ammonia because, in addition to
being highly toxic by virtue of being a heavy metal ion, it is
also a potent oxidizer.
In one or more embodiments, methods of chemically
treating water sources before distillation or filtration are
described in which an acid source containing no sulfates, or
substantially no sulfates (including sulfate-forming species),
is used in combination with a solution of hexavalent chro-
mium. In particular embodiments of the present disclosure,
chemical pretreatments in accordance with embodiments
disclosed herein may enable water recovery from urine or
other brines without excessive precipitation of poorly
soluble minerals including sulfates, alkaline carbonate and
bicarbonates such as calcium sulfate, calcium carbonate,
magnesium sulfate, magnesium carbonate, and other poorly
soluble minerals such as barium sulfate and silicon dioxide.
In addition, reduced precipitation may also prevent mineral
scaling of surfaces within distillation or filtration systems
during water purification operations.
In some applications, chemical pretreatments described
herein may be used in combination with a toilet or other
sanitation fixture that delivers a volume of the chemical
pretreatment, which combines with a urine source when the
toilet is flushed. When mixed with the chemical pretreat-
ment, the urine may be disinfected and, further, may be
stabilized to prevent or reduce urea hydrolysis and the
growth of bacteria and fungi during storage before subse-
quent distillation or filtration. When added to stabilize urine
for storage, the chemical treatments may provide additional
pH buffering of pretreated urine at pH levels of around 2 to
T
minimize corrosion of surfaces. Without this pH buffering
capacity, pH of pretreated urine can be as low as 1 in brines
when dilute urine is distilled.
In a particular embodiment, chemical pretreatments
5 described herein may be used in low pressure water recovery
systems such as those aboard the International Space Station
(ISS) that use a urine processor assembly (UPA) as the first
stage in processing urine into potable water. The UPA is a
closed loop system operating in a microgravity environment
io that receives urine from the Waste and Hygiene Compart-
ment (WHC) of the ISS. The WHC collects urine and adds
pretreatment chemicals to stabilize the urine until it can be
further processed for water extraction. Currently, the pre-
treatment is a solution based formulation that is comprised
15 of a mixture of concentrated sulfuric acid and an aqueous
solution of chromium trioxide, similar to the solution
described in U.S. Pat. No. 3,556,949, which is hereby
incorporated in its entirety by reference. The pretreatment
dose is delivered by a metering pump at about 3-4 mL of the
20 chemical pretreatment and 50 mL of flush water per toilet
flush. After flushing the WHC, the urine is delivered directly
to the UPA wastewater storage tank and is often processed
within 1-3 days, or may be transferred to a bladder tank and
stored for 30-180 days.
25 The UPA recovers water using sub-ambient pressure and
low temperature distillation. Once the water source is treated
with the chemical pretreatment or other pretreatment, it is
cycled within the UPA until a desired water recovery rate has
been achieved. During processing, urine organics, salts, and
30 minerals become more concentrated as the water molecules
are removed. A target water recovery rate for the UPA is 85%
recovery by volume, which had been predicted, based on
ground testing, to be sufficiently below the saturation poten-
tial that would cause mineral precipitates to form. Here,
35 recovery by volume is calculated from the ratio of the
volume of actual distillate to the total volume of pretreated
urine.
However, because prior chemical pretreatments applied to
the urine samples were based upon sulfuric acid, excess
40 sulfate ions initiated the precipitation of calcium sulfate as
the waste brine became concentrated at higher recovery
rates. The precipitates blocked small tubes within a distil-
lation assembly (DA) of the UPA and flooded the DA with
brine, ultimately leading to failure of the UPA on the
45 international space station. The gypsum precipitates, which
were not observed in extensive ground testing, have been
attributed to elevated in-flight levels of urinary calcium and
sulfate ions and additional sulfate from the sulfuric acid
formulation. As a result, the UPA was adjusted to operate at
5o a lower water recovery rate (70%) to minimize the potential
of precipitation in the DA.
Chemical pretreatments in accordance with the present
disclosure may allow for water recoveries of up to 88% from
flushed urine (e.g., 88% urine and 12% deionized water by
55 mass in some embodiments), even in high stress conditions
where the urine has a calcium concentration of less than or
equal to 260 milligrams of calcium per liter. In some
embodiments, the upper limit of the water recovery without
precipitation of solutes may also be dependent on a number
60 of other parameters that include, for example, calcium
concentration, sulfate concentration, pH, and, in the case of
urine purification from a waste disposal configuration, the
volume of raw urine relative to the water volume used in
flushing.
65 Because chemical pretreatments described herein use
acids without or substantially free of sulfates, poorly soluble
compounds formed from the combination of sulfates and
US 9,878,928 B1
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cations such as calcium remain soluble as water is extracted
and the waste brine is concentrated, which results in the
observed increase in overall water recovery without scaling
of hardware surfaces.
As an exemplary embodiment, chemical pretreatments of
the present disclosure may be used in applications where a
metering pump of a toilet hardware configuration delivers a
predetermined injection volume, e.g. a volume of about 2 to
about 5 milliliters in a non-limiting embodiment, of a
chemical pretreatment solution per flush of the toilet. For
example, current protocol on the ISS injects approximately
about 3 to 4 milliliters of chemical pretreatment and an
additional fifty milliliters of deionized water to a volume of
urine per flush of the toilet. The volume of urine per flush is
variable, with a historical average on the order of 200±50
milliliters. Thus, a sufficient volume of chemical pretreat-
ment may be added to give a final vol % of the total volume
of urine solution within the range of 0.25 vol % to 10 vol %
of chemical pretreatment at 20-25° C. in some embodiments,
from 0.5 vol % to 7 vol % at 20-25° C. in other embodi-
ments, and from 1.5 vol % to 5 vol % at 20-25° C. in yet
other embodiments. The amount of chemical pretreatment
may be adjusted depending on temperature- or pressure-
dependent variations of volume to maintain the same mass
required to reach the target concentration. For example,
solutions that are below the targeted temperature range may
require the addition of a smaller volume of chemical pre-
treatment, while solutions above the targeted range may
required the addition of a larger volume of chemical pre-
treatment.
Chemical pretreatments of the present disclosure may be
used with lesser or greater amounts of the volume used on
the ISS. Urinary calcium concentrations are not monitored
on the ISS, but a calcium concentration of 260 mg calcium
per liter of urine may be assumed as a "worst case scenario'
concentration (above all expected values) to determine the
allowable water recovery rate to minimize precipitation
potential during distillation of pooled urine from three
people.
Chemical pretreatments in accordance with embodiments
disclosed herein may contain a combination of an aqueous
solution of hexavalent chromium with an acid source. In one
or more embodiments, a chemical pretreatment may be
prepared by dissolving a hexavalent chromium salt into an
aqueous solution and mixing the solution with an acid, or by
dissolving hexavalent chromium salt directly into the acid.
Suitable sources of hexavalent chromium, Cr (VI), include
salts of hexavalent chromium such as chromium trioxide,
chromates such as potassium chromate, lithium chromate,
sodium chromate, dichromate salts such as sodium dichro-
mate, potassium dichromate, and the like. In other embodi-
ments, hexavalent chromium may be generated in solution
using electrolytic techniques known to oxidize chromium
from lower oxidation states to hexavalent chromium.
In one or more embodiments, hexavalent chromium may
be present in a water source subsequent to treatment at a
molar concentration that ranges from a lower limit selected
from the group of 1x10-5 M, 1x10-4 M, 1x10-3 M, and
2x10-3 M to an upper limit selected from the group of
1 x10-3 M, 0.015 M, and 0.05 M, where any lower limit may
be used in combination with any upper limit. For example,
in one or more embodiments, the concentration of hexava-
lent chromium in a water source subsequent to treatment
may be in a range of about 500 mg/L to about 3 g/L.
Acid sources that may be used in accordance with
embodiments of the present disclosure include mineral acids
such as phosphoric acid, hydrochloric acid, nitric acid,
8
hydrobromic acid, hydrofluoric acid, perchloric acid, and the
like. In addition, the acid source may be any acid sufficient
to maintain an overall solution pH of approximately pH 2,
which contains no, or substantially no, sulfates and when
5 added to a water source as part of chemical pretreatment, the
treated water source remains substantially free of precipi-
tates. Moreover, acid sources described herein may also
allow greater extraction of a water product from a treated
water source, while the concentrated waste product that is
io generated remains substantially free of precipitates.
As used herein, "substantially free of precipitates" means
that the amount of precipitate present in the solution may be
less than 5 wt % in some embodiments, less than 2.5 wt %
in other embodiments, less than 1 wt % in other embodi-
15 ments, less than 0.5 wt % in other embodiments, and
completely solid-free or precipitate-free in yet other embodi-
ments. Further, in some embodiments, the term precipitates
may be used to reference mineral crystals or other solids that
are 10 microns in size or greater which are a source of
20 scale/foul the hardware surfaces and small conduits of a
distiller or other purification apparatus; this term may be
viewed in contrast with colloids and other particulates
smaller than 10 microns such as organic particles that may
not produce scale or other residues that negatively affect
25 purification hardware.
In one or more embodiments, the chemical pretreatment
may contain an acid source at a relative percent by total mass
of the pretreatment (mass %) that ranges from 20 mass % to
100 mass %, a chromium trioxide, where present, in an
30 amount that ranges from 1 mass % to 15 mass %, and a
balance of water or an aqueous fluid for a given pretreat-
ment. The final mass density of the pretreatment solutions
may range from 1.0 g/mL to 1.7 g/mL in one or more
embodiments.
35 For example, in a particular embodiment, a chemical
pretreatment may be added to a water source at a volume
that is about 3.6 milliliters of pretreatment per liter of water
source and contains about 79.4% phosphoric acid, 14.4%
H2O, and 6.2% CrO3 by mass, wherein the concentration of
40 the acid in the phosphoric acid is about 85% by weight. In
another example, a chemical pretreatment may be added to
a water source at a volume that is about 3.3 milliliters of
pretreatment per liter of water source and contains about
77.3% phosphoric acid, 15.9% H2O, and 6.8% CrO3 by
45 mass, wherein the concentration of the acid in the phos-
phoric acid is about 85% by weight. In yet another example,
a chemical pretreatment may be added to a water source at
a volume that is about 3.0 milliliters of pretreatment per liter
of water source and contains about 74.9% of phosphoric
5o acid, 17.6% H2O, and 7.5% CrO3 by mass, wherein the
concentration of the acid in the phosphoric acid is about 85%
by weight.
In one or more embodiments, a water source treated with
chemical pretreatments in accordance with the present dis-
55 closure may remain substantially free of solids or precipi-
tates for a time period sufficient to allow for water extrac-
tion. Similarly, concentrated waste products generated may
remain substantially free of solids or precipitates after water
extraction. In both cases, the solutions may remain substan-
60 tially free of solids for a time period that ranges from a lower
limit selected from a group consisting of 1 day, 3 days, 5
days, 1 week, 1 month, and 6 months, to an upper limit
selected from the group of 5 days, 1 week, 1 month, 6
months, 9 months, and 12 months, where any lower limit
65 may be used in combination with any upper limit.
The period of time that the treated water source remains
stable may also depend on the particular application and the
US 9,878,928 B1
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presence or absence of contaminants such as fungus or other
microorganisms. Under clean conditions, the pretreatment is
effective for 12 months, but with fungal contamination, the
observed storage time may be reduced to about 3 months or
less before the fungal growth forms mats that are larger than
10 microns. The chemical pretreatment relies on an initial
shock of the hexavalent chromium oxidizer and low pH, and
over time a substantial percentage of the hexavalent chro-
mium may become inert trivalent chromium such that there
is no residual disinfectant remaining to protect against
fungal growth or regrowth.
The criticality of the presence of solids or precipitates
may be dependent on the given application. For example, the
presence of minimal precipitates or absence of precipitates
may be desirable in applications that require continuous
production of water product with a minimization of inter-
vention and of repair of a distillation or filtration apparatus,
such as operation in a closed environment or aboard the ISS.
On the other hand, in applications that involve batch pro-
cessing, or applications where repair and/or cleaning of a
purification apparatus are readily performed without imme-
diate danger, the threshold concentration of precipitates may
be higher than applications requiring continuous production.
In one or more embodiments, the acid and hexavalent
chromium may be added together to form a single chemical
pretreatment. However, for some acids such as hydrochloric
acid, one may add the acid and hexavalent chromium
sequentially before use to prevent adverse interactions
between the acid and hexavalent chromium which may
prematurely reduce the chromium.
EXAMPLES
Example 1.1
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TABLE 2
Relative volumes of oxidizer and acid
of Examples 1.2-1.4 in a pretreatment solution for
different injection volumes per WHC flush.
5
Injection
Volume, mL of Gram Gram
Urine mL per 30% Cr03 mL Mass Mass
Pretreatment Toilet Oxidizer of 85% of 30% of 85%
Solution flush solution H3PO4 Cr03 H3PO4
V 3.6 mL of 3.6 0.94 2.66 1.18 4.52
Phosphochromic
acid using 30%
Cr03 solution
3.3 mL of 3.3 0.94 2.36 1.18 4.01
15 Phosphochromic
acid using 30%
Cr03 solution
3.0 mL of 3.0 0.94 2.06 1.18 3.50
Phosphochromic
acid using 30%
20 
Cr03 solution
As used in the formulations in Table 2, the oxidizer
solution is 30% Cr03 and 70% Water by mass (4.29 molal).
The concentrated phosphoric acid, also known as orthophos-
25 phoric acid, was approximately 85% H3PO4 by mass (15%
water). All volumes recorded in Table 2 were obtained in
temperature conditions falling within the range of 20° C. to
25° C.
30 Example 1.2
35
In the following example, chemical pretreatment formu-
lations are prepared from hexavalent chromium and a num-
ber of compatible acid sources. Chemical pretreatments 40
were prepared by first making an oxidizer solution contain-
ing hexavalent chromium. The same chromium oxidizer
solution is used for all of the following pretreatment for-
mulations in this example.
Prior to formulation of chemical pretreatments with an 45
acid source, an aqueous hexavalent chromium (oxidizer)
solution was be prepared by dissolving 30 grams of chro-
mium oxide (Cr03) in 70 grams (i.e., 70 mL) of ultrapure
deionized (DI) water. When the Cr03 was completely dis-
solved and the solution reached room temperature, the 50
temperature was recorded and the mass density of the
solution was measured in a 10 mL volumetric flask. The
aqueous solution of chromium trioxide is 30% Cr03 solution
by mass and has 4.29 moles of hexavalent chromium per
kilogram of water (4.29 molal). The mass density of this 55
solution was measured to be 1.25±0.02 gm/L at 22° C. For
total chromium and hexavalent chromium analysis, 10 mL
of the oxidizer solution was collected. The mass density of
the 30% Cr03 solution was measured in a 10 mL volumetric 60
flask and verified that it was within the range of 1.25±0.02
g/mL at 22° C.
Chemical pretreatments based on phosphoric acid and
hexavalent chromium are provided in Table 2. The proce-
dure for making the pretreatment solution was based on the 65
volumes for a single flush of the waste and hygiene com-
partment (WHC, i.e., a toilet) of the ISS.
A chemical pretreatment formulation containing hexava-
lent chromium and phosphoric acid was designed in order to
prepare 100 mL of solution for use in a WHC toilet at a 3.6
mL injection volume per flush. The chemical pretreatment
was prepared by transferring 26.1 mL (32.6 grams) of a 30%
Cr03 oxidizer solution (mass density- 1.25±0.02 g/mL) to a
flask and adding 73.9 mL (125.6 grams) of 85% phosphoric
acid (mass density=1.7 g/mL). All volumes were verified by
measuring the mass of flask at each step in procedure
(empty, with oxidizer, with oxidizer and acid). As designed,
the formulation could be scaled-up to produce five liters of
the chemical pretreatment to fill the tank on the ISS and
would stabilize about 314 liters of raw urine.
Example 1.3
A chemical pretreatment formulation containing hexava-
lent chromium and phosphoric acid was designed in order to
prepare 100 mL of solution for use in a WHC toilet at a 3.3
mL injection volume per flush. The chemical pretreatment
was prepared by transferring 28.5 mL (35.6 grams) of the
30% CO3 oxidizer solution to a tared flask and adding 71.5
mL (121.6 grams) of 85% phosphoric acid. All volumes
were verified by measuring the mass of the flask at each step
in procedure (empty, with oxidizer, with oxidizer and acid).
As designed, the formulation could be scaled-up to produce
five liters of this solution to fill the pretreatment tank on the
ISS and would stabilize about 286 liters of raw urine.
Example 1.4
A chemical pretreatment formulation containing hexava-
lent chromium and phosphoric acid was designed in order to
prepare 100 mL of solution for use in a WHC toilet at a 3.0
mL injection volume per flush. The chemical pretreatment
was prepared by transferring 31.3 mL (39.2 grams) of the
US 9,878,928 B1
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30% oxidizer solution to a weighed flask and adding 68.7
mL (116.7 grams) of 85% phosphoric acid. All volumes
were verified by measuring mass of flask at each step in
procedure (empty, with oxidizer, with oxidizer and acid).
Five liters of this solution would be required to fill the
pretreatment tank on the ISS and a scaled-up formulation
based on the above would stabilize about 262 liters of raw
urine.
Temperature during the formulation of the pretreatment
solution determines the final volume of the chromium-water
solution. Solutions may be susceptible to expansion due to
temperature variations, and thus the preparation procedures
should be maintained within the specified 20-25' C. tem-
perature range to minimize variation of results. Preparation
outside of that temperature range may require adjustment to
account for variations in volume experienced by thermal
expansion or contraction.
Additionally, water may be provided to minimize viscos-
ity and density of the pretreatment solution as required to
make the chemical pretreatments suitable for injection into
a urine stream by pump with the toilet. However, for other
embodiments, chromium trioxide may be dissolved directly
into 85% phosphoric acid up to its solubility limit, without
the addition of water.
Example 1.5
In another example, one liter of the chemical pretreatment
solution using phosphoric acid (H,PO,) was prepared by
dissolving 24.3 g of CrO, in 147 mL of deionized water.
Next, 853 mL of 85% H,PO, was added to the 147 mL of
chromium solution to make 1 L of pretreatment solution.
The pretreatment solution was 89.4% concentrated H,PO,
(includes water contained in concentrated H,PO,), 9.1%
12
nitric acid (mass density=1.42 g/mL). Appropriate volumes
were verified by measuring mass of flask at each step in
procedure (empty, with oxidizer, with oxidizer and acid).
The pretreatment solution was 61.4% concentrated HNO,
5 (includes water contained in concentrated HNO,), 27.0%
water, and 11.6% chromium trioxide by mass. Five liters of
this solution would be required to fill the pretreatment tank
on the ISS, and a scaled-up formulation based on the above
would stabilize about 417 liters of raw urine.
10 
Example 2
In the following example, the solubility of calcium sulfate
(gypsum) in simulated urine was studied for samples con-
15 
taining various formulations of chemical pretreatment. Gyp-
sum has a solubility of 2.1 g/L at 20' C. at standard pressure
in water and is significantly less soluble than comparative
salts like sodium chloride, which has a solubility of 359 g/L.
Moreover, the solubility of gypsum is also dependent on
20 other factors including the presence and/or addition of other
salts or changes in pH.
In the sequence of tests conducted, on-orbit urine was
simulated with a urine ersatz formulation developed by
Verostko, which has a theoretical ionic calcium concentra-
25 
tion of 260 mg/L, equal to the maximum urinary calcium
concentration expected in-flight. This concentration is com-
pared with the calcium concentration in standard urine,
which has a mean calcium concentration of about 188 mg/L.
More details regarding the ersatz formulation may be found
in Verostko et al., "Ersatz wastewater formulations for
30 
testing water recovery systems," NASA 2004-01-2448,
which is hereby incorporated by reference. The ersatz for-
mulation also contains 22.5 g of urea/L of urine. The
concentration of major solutes in urine ersatz and augmented
urine are listed in Table 3.
TABLE 3
Theoretical concentrations of major solutes in urine ersatz
and augmented urine used in Example 2.
Total Total
Total Total Ammonia Organic
Cl_ PO4 SO4 Na' Nitrogen K' Ca" Mg" Carbon
(mg/L) (mg/L) (mg/L) (mg/L) (mg/L) (mg/L) (mg/L) (mg/L) (mg/L)
Urine 5600 2300 3000 3000 260 2000 260 84 8500
Ersatz
Formulation
Augmented No 3100 3000 No No No 260 No 9200
Urine target target target target target
water (used to dissolve CrO,), and 1.5% chromium trioxide
by mass. Five liters of solution would be required to fill the
pretreatment tank on the ISS, and a scaled-up formulation
based on the above would stabilize 254 L of raw urine.
Example 1.6
While the exemplary formulations above utilized phos-
phoric acid, other acid sources such as hydrochloric acid or
nitric acid may be used in other embodiments to reduce the
required injection volume, depending on the constraints of
the distillation system.
An example of a chemical pretreatment formulated with
nitric acid was formulated as a total volume of 226 mL and
was prepared by transferring 94 mL (117.5 grams) of 30%
CrO, oxidizer solution (mass density-1.25±0.01 g/mL) to a
weighed flask and by adding 132 mL (187.4 grams) of 70%
50
Samples of ersatz were treated with various chemical
pretreatments. In order to determine the total gypsum capac-
ity of the samples, an excess of gypsum crystals was added
until the solutions reached saturation. The solutions were
55 then stirred for 7 days to reach chemical and physical
equilibrium. Saturated solutions were filtered using glass
fiber filters (0.7 micrometer pore size), and the filtrate was
analyzed by ion chromatography for total dissolved calcium
and sulfate concentrations.
60 The solubility of gypsum in brine ersatz containing the
various acid pretreatments is shown in FIG. 1, which shows
that brines treated with phosphoric acid, hydrochloric acid,
and nitric acid exhibit a greater capacity to solubilize
gypsum than the comparative baseline formulation contain-
65 ing sulfuric acid. This result may be attributed to the
common ion effect in which the formation of ionic precipi-
tates is accelerated by the addition of ions to the solution that
US 9,878,928 B1
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are part of the precipitate. Here, the addition of chemical
pretreatments containing sulfuric acid as the acid source
leads to an increase in the total concentration of sulfates in
solution, which then drives the calcium sulfate equilibrium
to favor the formation of a calcium sulfate precipitate in 5
accordance with Le Chatelier's principle.
FIG. 1 also shows that the solubility of gypsum increases
slightly with decreasing pH for phosphoric acid, hydrochlo-
ric acid, and nitric acid, whereas the solubility decreases
with decreasing pH for the comparative baseline sulfuric 10
acid formulation. The overall effect of the alternative acids
compared to sulfuric acid was a doubling in the solubility of
gypsum in the ersatz brine, which corresponds to 84% water
recovery.
15
Example 3
Testing with the ersatz brine in Example 2 confirmed that
the alternative acids are effective at increasing the solubility
of particular minerals, including calcium sulfates, in ersatz 20
brine solutions compared to an solutions treated with the
sulfuric acid by a factor of about two. Example 2 was
conducted by equilibrating artificial urine brine solutions
with solid-phase gypsum crystals and measuring the amount
of calcium that would dissolve. Gypsum was the only source 25
of calcium in the ersatz.
In Examples 3 and 4, testing of chemical pretreatments
was shifted from urine ersatz to real urine solutions with
augmented calcium concentrations in order to study the
mineral solubility during the process of actual distillation. 30
Experiments were conducted to evaluate the effectiveness of
the alternative acids at preventing precipitation of minerals
during distillation of urine samples. The question asked was
whether the alternative acids would permit distillation of
augmented urine to 85% recovery without precipitation of 35
minerals.
The effect of three different oxidizer (hexavalent chro-
mium) concentrations were measured: no oxidizer, a
reduced oxidizer dose (0.002 M); and the baseline oxidizer
dose (0.015 M) in pretreated urine. The main parameter used 40
to monitor the quantity of mineral precipitates was the mass
concentration of fixed suspended solids (FSS) obtained by
filtering solids from the treated urine both before and after
distillation to 15% of the original volume. In addition, the
mass concentration of volatile suspended solids (VSS) was 45
used as a measure to quantify the precipitation of uric acid,
a poorly soluble organic compound found in urine.
The goal was to determine the type of mineral acid and the
oxidizer concentration (0.0 M, 0.002 M, and 0.015 M) that
minimized both inorganic and organic precipitates, the total 50
suspended solids (TSS), in concentrated brines obtained
after 85% of the water component has been removed. For the
alternative acids, a determination of the dose size required to
reach pH 2 was also made in order to maintain a proper
comparison to the equivalent pH of the comparative baseline 55
sulfuric acid pretreatment formulation. In this case, applied
chemical treatments contained 85% phosphoric acid, 70%
nitric acid, and 37% hydrochloric acid, respectively, and the
comparative baseline formulation contains about 98% sul-
furic acid. 60
In Examples 3 and 4, urine was collected from volunteers
at the Johnson Space Center (JSC). Urine was combined into
batches, made up of 20% first morning void and 80% normal
urine output. Each batch of urine also corresponded with a
5:1 male-to-female donor ratio. The calcium ion concentra- 65
tion was measured in the raw urine prior to adding the
augmentation chemicals. Once the calcium concentration
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was measured, inorganic and organic chemicals were added
to reach 260 mg of Ca/L of raw urine to represent a worst
case scenario with respect to calcium precipitation.
The augmented urine was pretreated and distilled under
pressure and temperature conditions simulating nominal
operation of the distillation assembly (DA) on the ISS. The
solutions used in initial testing represent the worst-case
(most concentrated) in-flight urine solute concentrations.
The maximum calcium concentration was assumed to be
260 mg of calcium/L of raw urine, based upon a statistical
analysis of in-flight urinary data. After stabilization chemi-
cals and flush water are added, the calcium concentration is
reduced to 206 mg of calcium/L of pretreated urine.
The values in Table 4 are an updated formulation of
flushed urine based on recycled filter tank assemblies
returned from the ISS and the concentrations of stabilization
agent and flush water used for all testing in this example.
The theoretical concentration of total chromium is 0.8
g-chromium/L of pretreated urine solution (0.015 M) using
the baseline pretreatment on the ISS shown in Table 4. DI
water was used to represent the Waste and Hygiene Com-
partment (WHC) flush water.
TABLE 4
Pretreated urine formulation
Constituent volume
Raw urine 1 L
DI (flush) water 0.265 L
Pretreatment solution 15.9 mL
Total pretreated urine solution 1.281 L
For the distillation assays, augmented urine was pre-
treated nominally with flush water and an acid. Specifically,
each sample contained 3 mL of the chemical pretreatment,
200 mL raw urine, and 50 mL of water Prior to distillation,
the pretreated urine samples were stored at least 1 day at
ambient temperature (20° C. (68° F.) to 25° C. (77° F.)) to
allow the solution to approach an equilibrium state for the
slow oxidation-reduction processes.
A rotary evaporator (Rotavapor® R-215 (BUCHI
Labortechnik AG, Switzerland)) was used to distill the
pretreated urine. The initial mass of the pretreated urine to
be distilled was measured in the glass evaporation flask on
a 3-kg scale. The mass was recorded to the nearest 0.1 g. The
initial mass of pretreated urine ranged from 300 to 500 g.
The evaporation flask was connected to the stop cock and
vapor duct of the rotary evaporator.
The pretreated urine was distilled under vacuum to simu-
late nominal distillation assembly (DA) conditions. The
absolute pressure within the evaporation flask was main-
tained at 60 to 80 mbar and the associated vapor temperature
was measured as 39° C. (102° F.) to 41° C. (105° F.). The
evaporation vessel rotated at 45 revolutions per minute
half-submerged in a heating bath, which was filled with tap
water. The heating bath temperature was controlled at 60° C.
(140° F.)±5° C. nominal. The chiller liquid temperature was
set to 10° C. (50° F.) to 15° C. (59° F.). Distillate condensed
on glass surfaces in the condenser and drained by gravity
into the distillate collection flask. The percent recovery was
calculated by measuring the mass of brine solution at the end
of a distillation run and comparing it to the initial mass of
pretreated urine.
During distillation, progress was monitored by stopping
the process, allowing the pressure and temperature to reach
ambient conditions, and determining the mass of the evapo-
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ration flask. The mass of remaining brine was determined
and the recovery rate was calculated therefrom based upon
the change from the initial measured value. Distillation was
continued to 85% water recovery, which corresponds to a
reduction of the brine fraction to 15% of the original sample
volume. After distillation, the brine was stored in the evapo-
ration flask for 1 week at 25° C. (77° F.) to allow solid-liquid
phase equilibrium by providing sufficient time for crystal
formation if the brine was supersaturated with respect to a
mineral.
Following one (1) week of storage, the mass of brine was
re-measured and the mass density of the brine was measured
with a hydrometer or in a volumetric flask on a scale. A
measured mass of brine was passed through a 0.7-microm-
eter glass fiber filter to measure Total Suspended Solids
(TSS), Fixed Suspended Solids (FSS), and Volatile Sus-
pended Solids (VSS) and to isolate any crystals. The evapo-
ration flask and the solids on the filter were rinsed thor-
oughly to collect any crystals that adhered to the flask's glass
surfaces. All of the brine from the evaporation flask was
passed through the filter paper. If the quantity of suspended
solids was significant, more than one filter paper was used.
The soluble concentration of calcium and the mass quan-
tity of precipitates in distilled brines were the key param-
eters monitored to determine the reliability and effectiveness
of the alternate acid formulations. The main precipitate of
interest for the given pretreatment chemicals was calcium
sulfate; other precipitates of interest were phosphates and
uric acid.
The masses of precipitates were monitored by measuring
TSS and FSS retained on a glass fiber filter with an average
pore size of 0.7 micrometers (0.6 to 0.8 micrometers nomi-
nal). The pretreated urine and brine were analyzed for TSS,
FSS, and VSS. Measuring FSS and VSS enabled quantifi-
cation of organic and inorganic suspended solids. The results
are illustrated in FIG. 2, which shows the mass concentra-
tion of FSS and VSS in treated augmented urine that was
acidified but not oxidized by the addition of hexavalent.
Samples denoted "A" and ` B" represent duplicate TSS
measurements obtained from urine solutions after the addi-
tion of chemical pretreatment.
For samples without the hexavalent chromium oxidizer,
the largest contribution to the TSS is uric acid, which
precipitates at 1 to 2 g/kg of brine for all acids, including the
comparative baseline formulation containing H2SO4. In this
study, uric acid crystals were identified based on their amber
color and morphology. The formation of uric acid crystals in
acidified urine brines is a slow process compared to the
formation of gypsum crystals. The induction time is on the
order of 1 week for uric acid crystals to form from super-
saturated urine solutions. Uric acid is poorly soluble and will
precipitate in pretreated urine even without concentration by
distillation.
Example 4
In the following Example 4, samples were formulated as
described above for Example 3, with the exception that the
acid sources were supplemented with hexavalent chromium
at a "reduced" dose of 0.002 M or a "full" dose of 0.015 M
in the pretreated urine. With particular respect to FIG. 3,
chemical treatment formulations are assayed wherein the
samples denoted "ISS" contain a hexavalent chromium at
the full dosage of 0.015 M, and samples denoted "reduced"
contain 0.002 M hexavalent chromium.
Samples containing phosphoric acid, hydrochloric acid,
and nitric acid exhibit significantly reduced mineral precipi-
16
tation after 85% water recovery when compared to samples
treated with sulfuric acid and oxidizer. The error bars
represent±one standard deviation for triplicate distillations
of augmented urine samples. FSS values are less than 30
5 mg/kg of brine for all three alternative acids compared to an
average FSS of 1.9 g/kg for the baseline H2SO4. The VSS
values are less than 125 mg/kg of brine for all three
alternative acids and 320 mg/kg (reduced oxidizer dose) to
580 mg/kg (full oxidizer dose) for the sample treated with
10 
sulfuric acid and hexavalent chromium.
The concentration of dissolved calcium ions was mea-
sured for all the filtered brines after being stored for 1 week.
All of the alternative acid brines phosphoric acid, nitric
15 acid, and hydrochloric acid when at 85% recovery had
dissolved concentrations of about 1,400 mg-calcium/L com-
pared to 700 mg-calcium/L for the baseline sample contain-
ing the H2SO4 pretreatment.
The new formulations would use the same hardware that
20 
is currently used on the ISS. The current pretreatment
formulation would be launched and transported in a 5-L tank
that links to the pretreatment/water dispenser pump of the
Russian toilet in the WHC. The new formulations prepared
with phosphoric or nitric acid would use the same 5-L tank.
25 
In the case of hydrochloric acid formulation, two separate
tanks would be required because concentrated hydrochloric
acid is not compatible with the oxidizer. The relative com-
positions of the formulations are listed in Table 5. Dosing
requirements to achieve equivalent pH values as the baseline
30 pretreatment solution using sulfuric acid are given in Tables
6-9.
TABLE 5
Relative mass content of the pretreatment solution
35 in 5-L tank prior to pretreatment of urine.
Mass Density
of Pretreat-
ment Solution
at 20° C.
Concentrated
Acid
Solution
Water to
Dissolve
Cr03 Cr03
40
Baseline 1.35 g/mL 36.5% 54.5% 9.0%
pretreatment
solution with
98% H2SO4
Alternative 1.62 g/mL 89.4% 9.1% 1.5%
45 
pretreatment
solution with
85% H3PO4
Alternative 1.35 g/mL 75.4% 21.1% 3.5%
pretreatment
solution with
70% HNO3
50 Alternative 1.20 g/mL 100% 0% 0%
pretreatment 1.17 g/mL 0% 85.8% 14.2%
solutions with
37% HCl
55 With particular reference to Table 5, one liter of the new
pretreatment solution using H3PO4 is prepared by dissolving
24.3 g of Cr03 in 147 mL of DI water. Next, 853 mL of 85%
H3PO4 are added to the 147 mL of chromium solution to
make 1 L of pretreatment. The pretreatment solution is
60 89.4% concentrated H3PO4 (includes water contained in
concentrated H3PO4)1 9.1% water (used to dissolve Cr03)1
and 1.5% chromium trioxide by mass. Five liters of this
solution would be required to fill the pretreatment tank on
ISS. Five liters of solution would be sufficient to stabilize
65 about 254 L of raw urine.
One liter of the new pretreatment solution using HNO3 is
prepared by dissolving 47 g of Cr03 in 284 mL of DI water.
US 9,878,928 B1
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Next, 716 mL of 70% HNO3 are added to the 284 mL of
chromium solution to make 1 L of pretreatment solution.
The pretreatment solution is 73.4% concentrated HNO3
(includes water contained in concentrated HNO3), 21.2%
water, and 3.5% chromium trioxide by mass. Five liters of
this solution would be required to fill the pretreatment tank
on ISS and would stabilize about 490 liters of raw urine.
Due to oxidation of chloride ions by hexavalent chro-
mium, hydrochloric acid is less compatible with the oxidizer
solution at the tested concentrations. To minimize possible
stability problems, it may be beneficial to add the oxidizer
and hydrochloric acid to the water source separately or soon
after mixing before degradation becomes an issue. While
vapor pressure and corrosiveness of 37% hydrochloric acid
may be problematic for space flight applications, it may still
be beneficial for land-based water purification applications
where mixing hydrochloric acid with the oxidizer separately
is more convenient, lower volumes of chemical pretreatment
are preferred, or where hydrochloric acid is the byproduct of
a simultaneous purification process, for example.
TABLE 6
Volume and mass of pretreatment solutions 25
to be injected in each dose with flush water.
Nominal
Doses per
Liter of Raw mL-Pretreat- mL-Flush
Urine Based ment Solution Water 30
on 9 Returned per Dose per Dose
RFTAs Acid (I injection) (I injection)
5.3 98% 3.0 50
H2SO4
35
5.3 85% 3.7 50
H3PO4
5.3 70% 1.9 50
HNO3
5.3 37% HCI 2.5 50
40
TABLE 7
Concentrations of pretreatment chemicals
relative to raw urine for nominal dosing. 45
g-Pure Acid per g-Cr per kg
Acid kg of Raw Urine Raw Urine
98% H2SO4 (current 7.7 g-H2SO4/kg 1.0 g-Cr/kg
baseline operations 50
on ISS)
85% H3PO4 24.2 g-H3PO4/kg 0.25 g-Cr/kg
70% HNO3 7.2 g-HNO3/kg 0.25 g-Cr/kg
37% HCI 5.9 g-HCl/kg 0.25 g-Cr/kg
55
TABLE 8
Concentrations of pretreatment chemicals in
flushed, pretreated urine for nominal dosing.
60
g-Pretreatinent mL-Pretreat-
Solution ment Solu-
per kg of tion per kg
Acid Raw Urine of Raw Urine
98% H2SO4 (current 21.5 g/kg 15.9 mL/kg
baseline operations 65
on ISS)
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TABLE 8-continued
Concentrations of pretreatment chemicals in
flushed, pretreated urine for nominal dosing.
g-Pretreatinent mL-Pretreat-
Solution ment Solu-
per kg of tion per kg
Acid Raw Urine of Raw Urine
85% H3PO4 31.8 g/kg 19.6 mL/kg
70% HNO3 13.6 g/kg 10.1 mL/kg
37% HCI 15.9 g/kg 13.3 mL/kg
The values listed in Tables 7 and 8 are based on obtaining
a pH of 2 in the pretreated augmented urine. If the require-
ment can be increased to a pH greater than 2 in the future by
additional testing, the mass of pretreatment solutions could
be reduced. This change would require brine precipitation
testing and a long-term bacteria and mold challenge test at
a pretreated urine pH of about 2.2 to 2.3 before implemen-
tation.
TABLE 9
Concentrations of chemical pretreatments
in flushed pretreated urine (PTU) for nominal dosing.
g-Pure Acid g-Cr per kg of
Acid per kg of PTU PTU
98% H2SO4 (current 6.0 g-H2SO4/kg-PTU 0.78 g-Cr/kg-PTU
baseline operations
on ISS)
85% H3PO4 18.6 g-H3PO4/kg-PTU 0.19 g-Cr/kg-PTU
70% HNO3 5.6 g-HNO3/kg-PTU 0.19 g-Cr/kg-PTU
37% HCI 4.6 g-HCl/kg-PTU 0.19 g-Cr/kg-PTU
Three different strong acids were analyzed as a replace-
ment for H2SO4 in the assayed urine pretreatment formula-
tions. These alternative acids eliminated the supplementary
sulfate ions coming from sulfuric acid which reduce the
solubility of calcium in brines. The concentrated acids
studied were 85% H3PO4, 37% HCl, and 70% HNO3. The
effect of lowering the oxidizer concentration also was stud-
ied to save consumable mass and improve distillate water
quality.
Compared to previous in-flight methods in which water
recovery was limited to approximately -70% before mineral
precipitation created scaling and fouling problems, chemical
pretreatments in accordance with the instant disclosure
allow for increased water recovery rates (from brine
sources) of about 85% or more.
Embodiments described herein are directed to chemical
pretreatments that may be applied to a number of water
purification processes, particularly where the water source to
be treated contains brine and/or microorganisms. While
examples shown are directed to distillation processes, the
principles of enhancing recovery while minimizing the
formation of precipitates may also be applied to water
recovery processes that utilize filtration, e.g., membrane
filtration methods such as reverse or forward osmosis, a
combination of distillation and filtration, etc.
While the disclosure includes a limited number of
embodiments, those skilled in the art, having benefit of this
disclosure, will appreciate that other embodiments may be
devised which do not depart from the scope of the present
disclosure and appended claims. Moreover, embodiments
described herein may be practiced in the absence of any
element that is not specifically disclosed herein.
Although only a few example embodiments have been
described in detail above, those skilled in the art will readily
appreciate that many modifications are possible in the
US 9,878,928 B1
19
example embodiments without materially departing from
this disclosure. Accordingly, all such modifications are
intended to be included within the scope of this disclosure as
defined in the following claims. In the claims, means-plus-
function clauses are intended to cover the structures
described herein as performing the recited function and not
only structural equivalents, but also equivalent structures.
Thus, although a nail and a screw may not be structural
equivalents in that a nail employs a cylindrical surface to
secure wooden parts together, whereas a screw employs a
helical surface, in the environment of fastening wooden
parts, a nail and a screw may be equivalent structures. It is
the express intention of the applicant not to invoke 35 U.S.C.
§112, paragraph 6, or 35 U.S.C. §112(f), as applicable, for
any limitations of any of the claims herein, except for those
in which the claim expressly uses the words ` means for'
together with an associated function.
What is claimed is:
1. A method of extracting potable water, comprising:
treating a water source with a chemical pretreatment
comprising a hexavalent chromium and an acid to
generate a treated water source, wherein the concen-
tration of sulfate compounds in the acid is negligible,
and wherein treated water source remains substantially
free of precipitates after the addition of the chemical
pretreatment.
2. The method of claim 1, wherein the hexavalent chro-
mium is provided as an aqueous solution of chromium
trioxide.
3. The method of claim 1, wherein the acid is one or more
selected from a group consisting of phosphoric acid, nitric
acid, and hydrochloric acid.
4. The method of claim 1, wherein the acid is phosphoric
acid.
5. The method of claim 1, wherein the water source is
brine.
6. The method of claim 1, wherein the water source is
urine.
7. The method of claim 6, wherein one liter of the urine
is pretreated with about 3.6 milliliters of an aqueous solution
comprising about 79.4% phosphoric acid, about 14.4% H201
and about 6.2% CrO3 by mass, wherein the concentration of
the acid in the phosphoric acid is about 85% by weight.
8. The method of claim 6, wherein one liter of the urine
is pretreated with about 3.3 milliliters per liter of an aqueous
solution comprising about 77.3% phosphoric acid, about
15.9% H20, and about 6.8% CrO3 by mass, wherein the
concentration of the acid in the phosphoric acid is about 85%
by weight.
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9. The method of claim 6, wherein one liter of the urine
is pretreated with about 3.0 milliliters per liter of an aqueous
solution comprising about 74.9% phosphoric acid, about
17.6% H20, and about 7.5% CrO3 by mass, wherein the
5 concentration of the acid in the phosphoric acid is about 85%
by weight.
10. The method of claim 6, wherein the amount of
hexavalent chromium utilized is sufficient to prevent pre-
cipitation of uric acid in the urine.
11. The method of claim 1, wherein the amount of
10 hexavalent chromium in the chemical pretreatment is cal-
culated to produce a final concentration of about 0.75 grams
by mass of chromium per liter of the water source.
12. The method of claim 1, wherein the amount of
hexavalent chromium is sufficient to inhibit bacterial growth
15 in the water source.
13. The method of claim 1, wherein treating a water
source with a chemical pretreatment places the pH of the
water source into the range of pH 0.5 to pH 2.5.
14. The method of claim 1, further comprising the step of
20 distilling at least a portion of the treated water source to
extract potable water.
15. The method of claim 14, wherein the treated water
source is distilled to about 12 percent of the volume before
distilling and wherein the treated water source remains
25 substantially free of precipitates during the step of distilling.
16. The method of claim 1, further comprising filtering at
least a portion of the treated water source to extract potable
water.
17. The method of claim 16, wherein the treated water
30 source is filtered by a membrane process to about 12 percent
of the volume before filtering and wherein the treated water
source remains substantially free of precipitates.
18. A method of reducing the pH in urine to be distilled
for potable water extraction, comprising:
35 pretreating the urine before distillation with a pretreat-
ment solution comprising one or more acid sources
selected from a group consisting of phosphoric acid,
hydrochloric acid, and nitric acid, and further compris-
ing hexavalent chromium,
40 wherein the urine remains substantially precipitate free
after the addition of the pretreatment solution.
19. A method for reducing precipitation in urine to be
processed for water extraction, comprising:
mixing the urine with a pretreatment solution comprising
45 hexavalent chromium compound and phosphoric acid,
wherein the urine remains substantially precipitate free
after the addition of the pretreatment solution and
during processing for water extraction.
